Paul Lvesque - Theratechnologies CEO President
TH Stock | CAD 1.79 0.09 5.29% |
CEO
Paul Lvesque is CEO President of Theratechnologies
Age | 59 |
Address | 2015 Peel Street, Montreal, QC, Canada, H3A 1T8 |
Phone | 514 336 7800 |
Web | https://www.theratech.com |
Theratechnologies Management Efficiency
The company has return on total asset (ROA) of (0.0455) % which means that it has lost $0.0455 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (11.1686) %, meaning that it generated substantial loss on money invested by shareholders. Theratechnologies' management efficiency ratios could be used to measure how well Theratechnologies manages its routine affairs as well as how well it operates its assets and liabilities. As of the 7th of May 2024, Return On Equity is likely to grow to 1.39, while Return On Tangible Assets are likely to drop (0.44). At this time, Theratechnologies' Non Current Assets Total are very stable compared to the past year. As of the 7th of May 2024, Other Current Assets is likely to grow to about 10 M, while Total Assets are likely to drop about 65.2 M.Similar Executives
Found 3 records | CEO Age | ||
Matevz Mazij | Bragg Gaming Group | N/A | |
Sean Morrison | Diversified Royalty Corp | 49 | |
Scott Tannas | Western Investment | 62 |
Management Performance
Return On Equity | -11.17 | ||||
Return On Asset | -0.0455 |
Theratechnologies Leadership Team
Elected by the shareholders, the Theratechnologies' board of directors comprises two types of representatives: Theratechnologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Theratechnologies. The board's role is to monitor Theratechnologies' management team and ensure that shareholders' interests are well served. Theratechnologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Theratechnologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
MarieNoel Colussi, Vice President - Finance | ||
Jovan Antunovic, Senior Vice President and Chief Commercial Office | ||
Conor Walshe, General Manager - Theratechnologies Europe Limited | ||
Sheila Frame, Independent Director | ||
Paul Lvesque, CEO President | ||
Philippe Dubuc, Chief Financial Officer, Senior Vice President | ||
Paul Levesque, President, Chief Executive Officer, Director | ||
Andrew Molson, Independent Director | ||
Gerald Lacoste, Independent Director | ||
LLB LLM, General Secretary | ||
Dawn Svoronos, Independent Chairman of the Board | ||
Pierre Perazzelli, Vice President - Pharmaceutical Development | ||
LLB BA, VP Affairs | ||
Denis Boucher, Vice President - Communications and Corporate Affairs | ||
H MSc, Vice Resources | ||
Christian Marsolais, Senior Vice President - Scientific Affairs and Alliances | ||
John Leasure, Global Officer | ||
Paul Pommier, Independent Director | ||
Gilles Cloutier, Independent Director | ||
Gary Littlejohn, Independent Director | ||
Elif McDonald, Director Relations | ||
Jocelyn Lafond, Vice President - Legal Affairs, Corporate Secretary | ||
Alain Trudeau, Independent Director | ||
MBA MBA, Senior CFO | ||
Dale Weil, Independent Director |
Theratechnologies Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Theratechnologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -11.17 | ||||
Return On Asset | -0.0455 | ||||
Profit Margin | (0.23) % | ||||
Operating Margin | (0.14) % | ||||
Current Valuation | 98.85 M | ||||
Shares Outstanding | 45.98 M | ||||
Shares Owned By Insiders | 6.28 % | ||||
Shares Owned By Institutions | 50.72 % | ||||
Number Of Shares Shorted | 14.88 K | ||||
Price To Earning | (52.28) X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Theratechnologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Theratechnologies' short interest history, or implied volatility extrapolated from Theratechnologies options trading.
Currently Active Assets on Macroaxis
When determining whether Theratechnologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Theratechnologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Theratechnologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Theratechnologies Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Theratechnologies Stock, please use our How to Invest in Theratechnologies guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Complementary Tools for Theratechnologies Stock analysis
When running Theratechnologies' price analysis, check to measure Theratechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theratechnologies is operating at the current time. Most of Theratechnologies' value examination focuses on studying past and present price action to predict the probability of Theratechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theratechnologies' price. Additionally, you may evaluate how the addition of Theratechnologies to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Stocks Directory Find actively traded stocks across global markets | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |